Continuing to Advance the Venous Agenda: Long‐Term Insights From the CAVA Trial
Main Authors: | Andrea Obi, Geoffrey D. Barnes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.021659 |
Similar Items
-
Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study
by: Pascale Notten, et al.
Published: (2020-09-01) -
Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis
by: Mary Cushman, et al.
Published: (2020-07-01) -
FAVORABLE CLINICAL COURSE OF POSTTHROMBOTIC SYNDROME – THE INDICATOR OF THE EFFECTIVENESS OF TREATMENT OF DEEP VEIN THROMBOSIS
by: D.R. RADZHABOV, et al.
Published: (2019-09-01) -
New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial
by: Félix Rinfret, et al.
Published: (2022-08-01) -
Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review
by: Ke Xuan Li, et al.
Published: (2021-05-01)